Status:
COMPLETED
Switching to Duloxetine From Other Antidepressants
Lead Sponsor:
Eli Lilly and Company
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
A multicentre, randomised, open label study of out-patients with major depression who have failed to respond adequately to antidepressant treatment for their current episode of depression. The study c...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Male and female outpatients of at least 18 years of age, who meet criteria for Major Depressive Disorder (MDD)
- Currently non- or only partially-responsive to an SSRI antidepressant after at least 5 weeks of treatment
- Exclusion Criteria include:
- Current primary Axis I disorder other than MDD
- Previous diagnosis of bipolar disorder, schizophrenia, or other psychotic disorders
- Patients judged to be at serious suicidal risk.
- Serious medical illness
Exclusion
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
End Date :
March 1 2006
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT00191932
Start Date
August 1 2004
End Date
March 1 2006
Last Update
July 25 2006
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
Caen, France
2
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
Cherbourg, France
3
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
Palaiseau, France
4
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
Paris, France